COCETTA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.495
AS - Asia 1.896
EU - Europa 1.852
SA - Sud America 506
AF - Africa 416
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 17
Totale 8.223
Nazione #
US - Stati Uniti d'America 3.236
IT - Italia 773
SG - Singapore 703
CN - Cina 347
BR - Brasile 345
HK - Hong Kong 276
PL - Polonia 126
DE - Germania 118
SE - Svezia 106
VN - Vietnam 81
FI - Finlandia 76
GB - Regno Unito 59
UA - Ucraina 56
FR - Francia 54
NL - Olanda 52
IN - India 48
RU - Federazione Russa 43
MX - Messico 36
CA - Canada 34
IR - Iran 30
TR - Turchia 29
AT - Austria 26
CZ - Repubblica Ceca 26
EC - Ecuador 26
CH - Svizzera 25
AR - Argentina 23
ES - Italia 23
ID - Indonesia 21
HR - Croazia 19
MA - Marocco 19
PH - Filippine 19
ZA - Sudafrica 19
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
IE - Irlanda 18
JP - Giappone 18
VE - Venezuela 18
AO - Angola 16
BF - Burkina Faso 16
BZ - Belize 16
RS - Serbia 16
AU - Australia 15
CY - Cipro 15
DZ - Algeria 15
GM - Gambi 15
IQ - Iraq 15
IS - Islanda 15
NP - Nepal 15
PE - Perù 15
PY - Paraguay 15
AL - Albania 14
BA - Bosnia-Erzegovina 14
CO - Colombia 14
GT - Guatemala 14
IL - Israele 14
JM - Giamaica 14
LU - Lussemburgo 14
TH - Thailandia 14
TJ - Tagikistan 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
UZ - Uzbekistan 14
BJ - Benin 13
BY - Bielorussia 13
CM - Camerun 13
EE - Estonia 13
JO - Giordania 13
SD - Sudan 13
SI - Slovenia 13
BO - Bolivia 12
CL - Cile 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
GF - Guiana Francese 12
MW - Malawi 12
MY - Malesia 12
PS - Palestinian Territory 12
RE - Reunion 12
TZ - Tanzania 12
BB - Barbados 11
BD - Bangladesh 11
BS - Bahamas 11
ET - Etiopia 11
GE - Georgia 11
GH - Ghana 11
GN - Guinea 11
HN - Honduras 11
HU - Ungheria 11
KR - Corea 11
LV - Lettonia 11
ME - Montenegro 11
MK - Macedonia 11
MU - Mauritius 11
NE - Niger 11
NI - Nicaragua 11
PT - Portogallo 11
RO - Romania 11
SA - Arabia Saudita 11
SN - Senegal 11
XK - ???statistics.table.value.countryCode.XK??? 11
Totale 7.773
Città #
Ashburn 412
Singapore 408
Fairfield 291
Hong Kong 264
Padova 234
Chandler 222
Santa Clara 167
Woodbridge 147
Cambridge 145
Beijing 144
Ann Arbor 133
Seattle 126
Houston 114
Boardman 104
Wilmington 104
Bytom 87
Medford 68
Princeton 68
Los Angeles 64
Milan 56
Munich 54
New York 49
Des Moines 44
Helsinki 44
San Diego 36
Ho Chi Minh City 34
Warsaw 27
Malo 26
Nanjing 26
Rome 24
São Paulo 22
Roxbury 21
Brooklyn 19
Chicago 19
Redondo Beach 18
Baku 17
Buffalo 17
Mexico City 17
Turku 17
Dallas 16
Stockholm 16
Amsterdam 15
Denver 15
Dublin 15
Palermo 15
Zagreb 15
Montreal 14
Amman 13
Montevideo 13
Rio de Janeiro 13
Tashkent 13
Washington 13
Atlanta 12
Cagliari 12
Dushanbe 12
Falkenstein 12
Hanoi 12
Ouagadougou 12
Phoenix 12
Reykjavik 12
Tokyo 12
Belgrade 11
Belo Horizonte 11
Conakry 11
Dakar 11
Managua 11
Niamey 11
Parma 11
Tallinn 11
Vienna 11
Abidjan 10
Accra 10
Arezzo 10
Banjul 10
Bridgetown 10
Castries 10
Catania 10
Chennai 10
Cotonou 10
Guatemala City 10
Havana 10
Johannesburg 10
Libreville 10
Luanda 10
Naples 10
Phnom Penh 10
Podgorica 10
Poplar 10
Quito 10
Tehran 10
Ulan Bator 10
Andorra la Vella 9
Bishkek 9
Boston 9
Dar es Salaam 9
Harare 9
Lilongwe 9
Lima 9
Limassol 9
Luxembourg 9
Totale 4.573
Nome #
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 242
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 224
Mitochondrial Involvement in Cisplatin Resistance 224
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy 191
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 183
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 183
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 175
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 158
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 155
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 151
Polyoxometalates-peptides conjugates for cancer cell targeting: a structural investigation 149
Lindqvist polyoxovanadate-peptides conjugates for cancer cell targeting 147
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 146
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 145
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 145
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 143
New insights in cisplatin-resistance: role of metabolic reprogramming in cancer cells 142
Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review 138
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 132
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 129
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 127
Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium 126
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 119
Milk kefir enriched with inulin-grafted seed extract from white wine pomace: chemical characterisation, antioxidant profile and in vitro gastrointestinal digestion 119
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 117
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 115
The SARS-CoV-2 spike protein binds and modulates estrogen receptors 111
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 108
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression 105
Anti-senescence activity of Salvia Haenkei on a skin cellular model 105
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives 103
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 102
Potential effect of Salvia Haenkey on in vitro wound healing 100
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy 100
Metabolic reprogramming in triple negative breast cancer cells: role of glutamine and glucose in cisplatin resistance 98
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 97
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 96
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 95
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 95
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 95
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 94
Natural compounds as metabolic modulators in resistant cancer cells models 92
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 91
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 90
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 89
Role of mitochondria in cisplatin-resistance phenomena 89
Links between cancer metabolism and cisplatin resistance 89
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 87
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 86
Mitochondrial remodeling involved in cisplatin resistance 84
Mitochondrial alterations involved in cisplatin resistance phenomena 84
Mitophagic/autophagic inhibitors as new strategy to overcome cisplatin resistance in cancer 84
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 83
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 82
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 82
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 82
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 80
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction 77
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 77
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 77
GLUTAMINE METABOLISM IN TRIPLE-NEGATIVE BREAST CANCER AND ITS ROLE IN CISPLATIN RESISTANCE 76
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 75
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins 74
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 74
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 74
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 73
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 73
Natural compounds as metabolic modulators in resistant cancer models 73
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 70
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 68
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 67
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 66
Natural compounds as metabolic modulators in resistant cancer cell models 64
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 62
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 56
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 52
Sviluppo di un decongestionante nasale a base fitoterapica 49
Silybin glycolysis inhibitor as promising agent in chemotherapy 48
Totale 8.328
Categoria #
all - tutte 27.132
article - articoli 15.521
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 266
Totale 42.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 27 30 65 40 65 68 84 34
2021/2022667 17 117 42 22 23 69 27 39 80 16 29 186
2022/2023598 129 46 21 36 120 59 6 32 80 3 47 19
2023/2024554 24 59 60 45 42 76 49 70 16 13 39 61
2024/20252.078 117 102 97 89 319 58 129 203 111 82 304 467
2025/20263.079 415 586 792 1.091 195 0 0 0 0 0 0 0
Totale 8.328